Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

Cognitive impairment is a core symptom domain of schizophrenia. The effect of antipsychotics, the cornerstone of treatment in schizophrenia, on this domain is not fully clear. There is some evidence suggesting that antipsychotics may partially improve cognitive function, and that this improvement ma...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nicole E. MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, Kenya A. Costa-Dookhan, Fernando Caravaggio, Philip Gerretsen, Araba Chintoh, Gary J. Remington, Valerie H. Taylor, Daniel J. Müeller, Ariel Graff-Guerrero, Margaret K. Hahn
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018-12-01
Serie:Frontiers in Psychiatry
Soggetti:
schizophrenia
antipsychotics
metabolic syndrome
cognitive dysfunction
mechanism
inter-relationship
Accesso online:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00622/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi